Biktarvy: A Complete Guide to Cost, Dosage, Side Effects & HIV Treatment

What is Biktarvy?

Biktarvy is a combination medication used to treat HIV-1 infection in adults and children weighing at least 14 kg. Manufactured by Gilead Sciences, Biktarvy combines three antiretroviral agents into a single pill: bictegravir, emtricitabine, and tenofovir alafenamide (TAF). It’s a highly effective HIV treatment, favored by both patients and healthcare providers for its convenience and efficiency.

Biktarvy belongs to a class of drugs called integrase strand transfer inhibitors (INSTIs) and is part of Antiretroviral Therapy (ART), a first-line approach to managing HIV infection. This combination therapy is designed to suppress HIV replication, helping patients achieve undetectable viral loads and preserve immune function.

This once-daily tablet is a convenient option for many individuals with HIV-1, as it does not require additional medications for most people. It’s well-tolerated, provides a simpler regimen, and is highly recommended for newly diagnosed HIV patients.

How Biktarvy Works: Mechanism of Action

Biktarvy combines three different agents, each working in a unique way to tackle the HIV virus. Together, these drugs block the HIV replication cycle at different stages, ensuring that the virus cannot multiply or damage the immune system.

Bictegravir: This is a next-generation integrase inhibitor. It binds to the integrase enzyme, preventing HIV from integrating its genetic material into the host cell’s DNA. Without this step, the virus cannot replicate and infect new cells.
Emtricitabine & Tenofovir Alafenamide (TAF): These two are nucleoside reverse transcriptase inhibitors (NRTIs), which stop the reverse transcription process. Reverse transcription is the step where HIV converts its RNA into DNA, allowing it to reproduce. By blocking this process, these drugs prevent the virus from replicating.

Biktarvy is considered a highly effective regimen, with some studies showing that patients who start treatment with it can achieve undetectable viral loads quickly. This means that the virus becomes so low in the bloodstream that it is untransmissible to others—achieving the goal of undetectable = untransmissible (U=U).

Dosage Guidelines for Biktarvy

Recommended Dosage

The standard recommended dosage of Biktarvy for both adults and children aged 14 kg and above is one tablet per day. This tablet contains 50 mg of bictegravir, 200 mg of emtricitabine, and 25 mg of tenofovir alafenamide.

Biktarvy can be taken with or without food. It’s designed to be a convenient, once-daily pill, which is a significant advantage for those who prefer fewer pills in their regimen.

Important Considerations

Kidney and Liver Health: Biktarvy does not require dose adjustments for patients with mild-to-moderate kidney or liver issues. However, those with severe renal impairment or advanced liver disease should consult a healthcare provider before use.
Missed Dose: If you miss a dose of Biktarvy and it’s less than 18 hours from your usual dose time, take it as soon as you remember. If it’s more than 18 hours, skip the missed dose and continue with your next scheduled dose. Never take two doses at once.
Alcohol and Biktarvy: While there’s no specific contraindication for alcohol use, excessive drinking is generally discouraged while on any HIV treatment, as it can affect liver function and interfere with the body’s ability to fight infections.

Always speak with your doctor about any adjustments or concerns related to Biktarvy dosage or interactions with other medications.

Monthly Cost of Biktarvy

While Biktarvy is highly effective, its cost without insurance can be significant. Without insurance, the monthly price of Biktarvy can range from $3,500 to $4,200 depending on the pharmacy and location. This makes it one of the more expensive HIV treatments, but there are programs that can help reduce these costs.

Cost Breakdown (Approximate)

Retail Price (no insurance): $3,500 – $4,200 per month
With Insurance: This will vary depending on your plan. Many insurance providers offer coverage for Biktarvy, bringing the monthly cost down significantly to $0 – $500 depending on copays, deductibles, and plan tiers.
Medicare/Medicaid: Generally covers the medication, but it may require prior authorization.

Unfortunately, as of now, there is no generic version of Biktarvy, and its patent is expected to last until 2033. This limits the availability of cheaper alternatives.

Biktarvy Savings: Patient Assistance Programs

One of the benefits of Biktarvy is Gilead’s commitment to accessibility. For patients struggling with the high cost of their medication, there are several resources available to help manage the cost.

Gilead’s Advancing Access Program

Gilead offers a patient assistance program called Advancing Access, which can provide copay cards for eligible patients. These cards can lower the cost of Biktarvy, sometimes to as little as $0 per month depending on the patient’s income and insurance situation.

Eligibility: Open to both insured and uninsured patients who meet certain income and insurance criteria.
How to Apply: Patients can apply online or ask their healthcare provider to assist with the process.

Other Savings Resources

NeedyMeds: A non-profit organization offering resources for discounted medication prices, including coupons for Biktarvy.
GoodRx: An online service that helps patients compare prescription drug prices across different pharmacies. GoodRx may offer discounted prices on Biktarvy if you don’t have insurance.

Patients should also ask their doctor or pharmacist for information on other local programs or resources for HIV treatment assistance.

Side Effects of Biktarvy

While Biktarvy is well-tolerated by many, like all medications, it has potential side effects. It is crucial to monitor how your body reacts to Biktarvy, especially when starting treatment.

Common Side Effects

Most patients experience only mild side effects that tend to subside over time. These may include:

Nausea
Diarrhea
Headache
Dizziness
Fatigue

These side effects are often temporary and may go away after the first few weeks of treatment.

Serious Side Effects

Though rare, serious side effects can occur, and it’s essential to be aware of them:

Liver issues: In rare cases, Biktarvy can cause elevated liver enzymes, which can lead to liver damage. People with hepatitis B or C may be at a higher risk.
Bone health: Some patients may experience bone density loss due to tenofovir alafenamide (TAF), which is an ingredient in Biktarvy. Regular bone monitoring may be necessary.
Lactic acidosis: This is a rare, but serious condition where lactic acid builds up in the blood, causing fatigue, weakness, or muscle pain.

Expert Comparison: Biktarvy vs Descovy

Both Biktarvy and Descovy are products of Gilead Sciences, but they have different applications in HIV care.

Biktarvy:

Used for HIV treatment in both treatment-naïve and treatment-experienced patients.
Contains three antiretroviral agents.
One-pill regimen: Biktarvy is a complete regimen with all three components in one tablet.
FDA-approved for HIV treatment in adults and children (14 kg+).
Does not require additional medications for most people.

Descovy:

Contains two components: Emtricitabine and TAF.
Not a complete regimen: Descovy is generally used in combination with another medication, such as an INSTI (integrase strand transfer inhibitor) like dolutegravir.
Used for HIV prevention (PrEP) in high-risk individuals and as part of combination therapy for HIV-infected patients.
Safer option for those with kidney concerns or low bone mineral density.

Which Should You Choose?

For full HIV treatment: Biktarvy is the preferred choice due to its complete regimen in a single pill.
For PrEP or HIV prevention: Descovy is a great option when taken with a second medication like an INSTI.

HIV Medication Overview: What You Need to Know

HIV (Human Immunodeficiency Virus) attacks the body’s immune system by destroying CD4 cells, which help fight infections. Without treatment, HIV can lead to AIDS (Acquired Immunodeficiency Syndrome), the most severe stage of HIV infection. With proper HIV treatment, however, people living with HIV can live long and healthy lives.

ART (Antiretroviral Therapy): The Lifesaver

Antiretroviral therapy (ART) refers to the use of medications to treat HIV infection. The goal of ART is to reduce the viral load (amount of HIV in the blood) to undetectable levels, allowing the immune system to regain strength and reduce the chance of transmission.

Biktarvy is one of the most effective and convenient options in ART, as it combines three powerful HIV drugs into a single tablet. The key to successful ART is consistent use and regular monitoring by a healthcare provider.

Final Thoughts: Is Biktarvy Right for You?

Biktarvy is a game-changer in HIV treatment. Its convenience, effectiveness, and low side effects make it a top choice for people living with HIV-1. With financial assistance programs and discounts available, it’s also an affordable option for many.

Always consult with your healthcare provider before starting any treatment, including Biktarvy, to ensure it’s the right choice based on your health needs and lifestyle.

Frequently Asked Questions (FAQs)

Is Biktarvy covered by insurance?

Yes, most insurance plans, including Medicaid and Medicare, cover Biktarvy with prior authorization. Be sure to check with your provider for details on coverage.

Can I take Biktarvy if I have hepatitis B?

Yes, but you will need regular monitoring. Stopping treatment can cause hepatitis B flare-ups, so it’s important to follow your doctor’s guidance.

Can I drink alcohol while on Biktarvy?

Moderation is key. While Biktarvy does not directly interact with alcohol, excessive drinking can harm your liver and overall health.

This article is intended for informational purposes only and should not replace professional medical advice.

Healthcare Galaxy

Biktarvy Breakthrough: Real Cost, Benefits, Side Effects & Hope